Formulation‐Dependent Modulation of Ibuprofen Absorption Kinetics in Fixed‐Dose Combinations: An Exploratory Analysis of the Dissolution–Absorption Relationship
Clinical Pharmacology in Drug Development · 2026
DOI: 10.1002/cpdd.70112 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Pharmacology in Drug Development, 2026. Verfasst von Satoko Ueda und 8 weiteren Autor:innen. Beteiligte Einrichtung: SSP Co., Ltd., an Opella Company, Shinjuku-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Ibuprofen, Acetaminophen, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit nennt 40 Literaturangaben. Gefördert von: SSP Co., Ltd.
Abstract (Originalsprache)
We conducted a pharmacokinetic study to compare two fixed‐dose combinations of ibuprofen/acetaminophen (IP‐TA and IP‐TB) with different formulation designs and excipient compositions, and explored how formulation differences influence ibuprofen pharmacokinetics by comparing in vitro dissolution and in vivo absorption profiles. In an open‐label, randomized, 2‐treatment, 2‐period, 2‐sequence crossover study, 24 healthy Japanese participants received a single oral dose of IP‐TA (ibuprofen 195 mg and acetaminophen 195 mg) or IP‐TB (ibuprofen 160 mg and acetaminophen 160 mg) under fasting conditions. Pharmacokinetic data were analyzed using a linear mixed‐effects model. Fraction absorbed (F a ) was estimated using the Loo–Riegelman method, and ibuprofen dissolution was evaluated at pH 1.2, 4.0, and 6.8. The relationship between weighted mean dissolution rates (D) and F a was examined. Ibuprofen absorption from IP‐TA was faster than from IP‐TB, as reflected by higher C max and greater early exposure, and these differences remained after dose normalization. Dissolution profiles showed temporal similarity with absorption profiles, particularly for IP‐TA. Analysis of F a also suggested a relatively high degree of synchronization between ibuprofen and acetaminophen absorption in IP‐TA. These findings indicate that formulation‐dependent differences in dissolution behavior may influence early ibuprofen absorption, although further studies are needed to clarify the underlying mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- SSP Co., Ltd., an Opella Company, Shinjuku-ku, Tokyo, Japan.
- Clinical and Nonclinical Development and Data Management, Opella Healthcare Group SAS, Neuilly-sur-Seine, France.
- Clinical Operations, GMPV, Opella Healthcare Group SAS, Aixial, an Alten company, Boulogne-Billancourt, France.
- Division of Clinical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Setagaya-ku, Tokyo, Japan.
- Clinical Research Center, Medical Co. Souseikai, Fukuoka Mirai Hospital, Higashi-ku, Fukuoka, Japan.
Förderung
- SSP Co., Ltd
Zitieren
APA
Ueda, S., Chujo, M., Miyadai, N., Rauch, C., Polivka, V., Saito, Y., Kawase, I., Uchida, N., & Matsuki, S. (2026). Formulation‐Dependent Modulation of Ibuprofen Absorption Kinetics in Fixed‐Dose Combinations: An Exploratory Analysis of the Dissolution–Absorption Relationship. Clinical Pharmacology in Drug Development. https://doi.org/10.1002/cpdd.70112
Vancouver
Ueda S, Chujo M, Miyadai N, Rauch C, Polivka V, Saito Y, et al. Formulation‐Dependent Modulation of Ibuprofen Absorption Kinetics in Fixed‐Dose Combinations: An Exploratory Analysis of the Dissolution–Absorption Relationship. Clinical Pharmacology in Drug Development. 2026. doi:10.1002/cpdd.70112
BibTeX
@article{Ueda2026,
author = {Ueda, Satoko and Chujo, Mitsuaki and Miyadai, Nobuo and Rauch, Clemence and Polivka, Valentine and Saito, Yujin and Kawase, Ichiro and Uchida, Naoki and Matsuki, Shunji},
title = {Formulation‐Dependent Modulation of Ibuprofen Absorption Kinetics in Fixed‐Dose Combinations: An Exploratory Analysis of the Dissolution–Absorption Relationship},
journal = {Clinical Pharmacology in Drug Development},
year = {2026},
doi = {10.1002/cpdd.70112}
}
EUVIMED